With the worldwide spread of the novel severe acute respiratory syndrome coronavirus‐2
(SARS‐CoV‐2) resulting in declaration of a pandemic by the World Health Organization …

The current monkeypox disease (MPX) outbreak constitutes a new threat and challenge for
our society. With more than 55,000 confirmed cases in 103 countries, World Health …

Community acquired pneumonia (CAP) is a leading cause of childhood morbidity
worldwide. Because of the rising antimicrobial resistance rates and adverse effects of …

Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by
pulmonary infections. The nasopharynx of infants is a major ecological reservoir of potential …

Group 2 innate lymphoid cells (ILC2s) orchestrate protective type 2 immunity and have been
implicated in various immune disorders. In the mouse, circulatory inflammatory ILC2s …

Background: Maintenance azithromycin therapy may improve pulmonary function in patients
with cystic fibrosis (CF) with Pseudomonas aeruginosa infection because of its …

Nasopharyngeal and oropharyngeal samples are commonly used to direct therapy for lower
respiratory tract infections in non-expectorating infants with cystic fibrosis (CF). We aimed to …

Abstract Objectives Patients with Cystic Fibrosis (CF) suffer from pancreatic insufficiency,
lipid malabsorption and gastrointestinal complaints, next to progressive pulmonary disease …

Wheezing and asthma are a growing cause of morbidity in children and adults. Treatment is
aimed at prevention of disease exacerbations and preservation of lung function. Respiratory …

Background Switching from intravenous antibiotic therapy to oral antibiotic therapy among
neonates is not yet practised in high-income settings due to uncertainties about exposure …